Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment

International Journal of Colorectal Disease

Volumn 27, Issue 10, 2012, Pages 1359-1367

  Homayounfar, K ^a   Bleckmann, A ^a   Conradi, L C ^a   Sprenger, T ^a   Beissbarth, T ^a   Lorf, T ^a   Niessner, M ^a   Sahlmann, C O ^a   Meller, J ^a   Becker, H ^a   Liersch, T ^a   Ghadimi, B M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Bilobar colorectal liver metastases; Liver resection; Multimodal treatment; Two stage resection

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRINOTECAN; LABETUZUMAB I 131; OXALIPLATIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL SURGERY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PORTAL VEIN OBSTRUCTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL;

ADULT; AGED; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PREOPERATIVE CARE;

EID: 84867016234     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1455-1     Document Type: Article

References (39)

1. Abdalla EK, Adam R, Bilchik AJ et al (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271-80
2. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-27
3. Poston G, Adam R, Alberts S et al (2005) Oncosurg: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23:7125-34
4. Folprecht G, Gruenberger T, Hartmann JT et al (2010) Cetuximab plus FOLFOX6 or cetuximab plus FOLFIRI as neoadjuvant treatment of nonresectable colorectal liver metastases: a randomized multicenter study (CELIM-study). Lancet Oncology 11:38-47
5. Jaeck D, Oussoultzoglou E, Rosso E et al (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037-51
6. Wicherts DA, de Haas RJ, Andreani P et al (2010) Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97:240-50
7. Sakamoto Y, Fujita S, Akasu T et al (2010) Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases?-An analysis of survival of 77 patients undergoing hepatectomy. J Surg Oncol 102:784-8
8. Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703-10
9. Ksienski D, Woods R, Speers C, Kennecke H (2010) Patterns of referral and resection among patients with liver-only metastatic colorectal cancer. Ann Surg Oncol 17:3085-93
10. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg 230:309-21
11. Andres A, Majno PE, Morel P et al (2007) Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol 15:134-43
12. Blazer DG 3rd, Kishi Y, Maru DM et al (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26:5344-51
13. Truant S, Oberlin O, Sergent G et al (2007) Remnant liver volume to body weight ratio≥0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22-33
14. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate response to treatment in solid tumors. J Natl Cancer Inst 92:205-16
15. Balzan S, Belghiti J, Farges O et al (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824-9
16. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254-62
17. Schmiegel W, Pox C, Adler G et al (2004) S3-Guidelines Conference "Colorectal Carcinoma" 2004. Z Gastroenterol 42:1129-77
18. Liersch T, Meller J, Bittrich M et al (2007) Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol 14:2577-90
19. Liersch T, Meller J, Sahlmann CO et al. Efficacy of repeated anti-CEA-radioimmunotherapy (RAIT) with 131iodine(I)-labetuzumab (phase-II study) in patients with colorectal cancer (CRC) after salvage resection of multiple liver metastases (CRLM). 2009 Gastrointestinal Cancers Symposium Proceedings, 2009;Abstract 459
20. Free statistical software R, version 2.12.2, www.r-project.org
21. Chun YS, Vauthey JN, Ribero D et al (2007) Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11:1498-1505
22. CoveyA, Brown KT, JarnaginWR et al (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247:451-5
23. Tanaka K, Kumamoto T, Matsuyama R et al (2010) Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 14:359-68
24. Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151-60
25. Brouquet A, Abdalla EK, Kopetz S et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011; Epub ahead of print
26. Garufi C, Torsello A, Tumolo S et al (2010) Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Br J Cancer 103:1542-7
27. Schmiegel W, Reinacher-Schick A, Arnold D et al (2008) Update S3-guideline "colorectal cancer" 2008. Z Gastroenterol 46:799-840
28. D'Angelica M, Kornprat P, Gonen M et al (2011) Effect on outcome of recurrence pattern after hepatectomy for colorectal metastases. Ann Surg Oncol 18:1096-103
29. Gold JS, Are C, Kornprat P et al (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome. Ann Surg 247:109-17
30. Homayounfar K, Liersch T, Niessner M et al (2010) Multimodal treatment options for bilobar colorectal liver metastases. Langenbecks Arch Surg 395:633-41
31. Mueller L, Hillert C, Möller L et al (2008) Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol 15:1908-17
32. Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-72
33. Nikfarjam M, Shereef S, Kimchi ET et al (2009) Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 16:1860-7
34. Rees M, Tekkis PP, Welsh FKS et al (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:125-35
35. Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer. A population-based study. Cancer 109:718-26
36. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-16
37. Portier G, Elias D, Bouche O et al (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976-82
38. Mitry E, Fields AL, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906-11
39. Folprecht G, Gruenberger T, Bechstein W. Progression free and overall survival after neoadjuvant treatment of colorectal liver metastases with cetuximab plus FOLFOX or FOLFIRI. Results of the CELIM study. ESMO 2011; abstract #6009